Sotera Health Company is a diagnostics & research business based in the US. Sotera Health Company shares (SHC) are listed on the NASDAQ and all prices are listed in US Dollars. Sotera Health Company employs 3,000 staff and has a trailing 12-month revenue of around $1.1 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $13.33 |
|---|---|
| 52-week range | $10.71 - $19.34 |
| 50-day moving average | $11.73 |
| 200-day moving average | $13.38 |
| Wall St. target price | $15.25 |
| PE ratio | 68.8947 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $0.19 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $13.33 from 2024-07-23
| 1 week (2024-07-17) | -0.15% |
|---|---|
| 1 month (2024-06-24) | 12.02% |
| 3 months (2024-04-24) | 18.28% |
| 6 months (2024-01-24) | -8.89% |
| 1 year (2023-07-24) | -30.32% |
|---|---|
| 2 years (2022-07-22) | -29.32% |
| 3 years (2021-07-23) | 22.79 |
| 5 years (2019-07-20) | N/A |
Valuing Sotera Health Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Sotera Health Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Sotera Health Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 69x. In other words, Sotera Health Company shares trade at around 69x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
However, Sotera Health Company's P/E ratio is best considered in relation to those of others within the diagnostics & research industry or those of similar companies.
Sotera Health Company's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.3738. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Sotera Health Company's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
However, it's sensible to consider Sotera Health Company's PEG ratio in relation to those of similar companies.
Sotera Health Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $527.4 million.
The EBITDA is a measure of a Sotera Health Company's overall financial performance and is widely used to measure a its profitability.
To put Sotera Health Company's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $1.1 billion |
|---|---|
| Operating margin TTM | 24.53% |
| Gross profit TTM | $557 million |
| Return on assets TTM | 7.07% |
| Return on equity TTM | 13.88% |
| Profit margin | 5.09% |
| Book value | $1.52 |
| Market Capitalization | $3.7 billion |
TTM: trailing 12 months
We're not expecting Sotera Health Company to pay a dividend over the next 12 months.
You may also wish to consider:
Over the last 12 months, Sotera Health Company's shares have ranged in value from as little as $10.71 up to $19.34. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sotera Health Company's is 2.06. This would suggest that Sotera Health Company's shares are significantly more volatile than the average for this exchange and represent a higher risk.
To put Sotera Health Company's beta into context you can compare it against those of similar companies.
Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems. The company also provides microbiological and analytical chemistry testing, as well as technical assistance, regulatory consulting, and advisory services. It serves medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials industries, as well as commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020.
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
Learn the basics of put options: what they are, how they work and a few examples.
A deep dive into the highlights and limitations of Frec.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out our 7 ideas for how to invest $10K to maximize your money.
Check out the best-performing ETFs so far in 2024.